What peptides actually are, which peptide-based medications are FDA approved, what the FDA's 2026 compounding review means, and how Amsara Health approaches peptide therapy.
Everyone Is Talking About Peptides. Let's Talk About What They Actually Are.
Your favorite wellness influencer is talking about peptides. Your biohacking friend is talking about peptides. Your closest girlfriends may be asking about GLP-1s, collagen peptides, "recovery peptides," or the latest thing they heard about BPC-157, sermorelin, GHK-Cu, or other peptide therapies.
So naturally, the questions start.
What are peptides? Are peptides safe? Which peptides are FDA approved? And how do you know whether peptide therapy is legitimate medical care or just another wellness trend?
At Amsara Health, we believe women deserve clear, medically grounded answers, especially during perimenopause, menopause, and beyond, when metabolism, body composition, sleep, energy, mood, libido, and recovery can all begin to shift.
Here is the truth: peptides are not new. Many peptide-based medications are already part of mainstream medicine. But not every peptide being promoted online is FDA approved, and not every compounded or "research-use" peptide has been reviewed by FDA for safety and effectiveness.
The distinction matters.
At Amsara, our licensed health providers may prescribe FDA-approved peptide-based medications when clinically appropriate, based on medical history, symptoms, goals, labs, contraindications, and ongoing monitoring.
What Are Peptides?
Peptides are short chains of amino acids. Amino acids are the building blocks of proteins, but peptides are more than "small proteins." In the body, many peptides act as signaling molecules, helping regulate biological processes such as appetite, blood sugar, fluid balance, hormone signaling, gastrointestinal function, pain pathways, and more.
Some peptides are naturally produced by the body. Others are manufactured as prescription medications. Familiar peptide-based or peptide-related therapies include insulin, GLP-1 receptor agonists, glucagon, oxytocin, vasopressin, somatostatin analogs, and certain hormone-regulating medications.
This is where the conversation can become confusing. The word "peptide" can refer to a well-studied FDA-approved medication, a compounded prescription, a supplement ingredient, a cosmetic ingredient, or an unapproved product sold online for "research use only."
Those are not the same thing.
Why Are Peptides Suddenly Everywhere?
Peptides have become part of the mainstream wellness conversation for several reasons.
First, GLP-1 and incretin-based medications changed the way many people think about metabolic health, appetite regulation, insulin resistance, and body composition. These therapies include peptide-based medications that act on pathways involved in glucose regulation and satiety.
Second, social media has accelerated interest in peptides marketed for recovery, skin, sleep, libido, injury repair, inflammation, body composition, and longevity. Some of these claims are being discussed far ahead of the clinical evidence.
Third, women in perimenopause and menopause are actively seeking better answers. When sleep changes, weight distribution shifts, workouts feel different, libido declines, or energy becomes unpredictable, it makes sense to look for advanced options.
The key is making sure those options are medically appropriate, evidence-informed, and prescribed by licensed health providers.
What Does "FDA Approved" Actually Mean?
When a medication is FDA approved, it means FDA has reviewed a specific drug product for safety and effectiveness for one or more specific uses. FDA approval applies to a specific product, dose, route of administration, manufacturing process, labeling, and indication.
That is very different from saying "this ingredient is popular," "this peptide is being studied," or "this substance is being discussed in a compounding context."
Here is the simplest way to understand the difference:
- FDA-approved peptide-based medication: A specific drug product has been reviewed by FDA for safety and effectiveness for specific indications.
- Compounded peptide: A pharmacy may prepare a customized medication under certain legal conditions, but the compounded medication itself is generally not FDA approved.
- Research-use peptide: A product labeled "for research use only" is not intended for human clinical use and should not be self-prescribed, self-injected, or used as a substitute for medical care.
This distinction is especially important right now because several peptides are moving through FDA's compounding review process. But movement through a compounding review is not the same as FDA approval.
Which Peptides Are FDA Approved?
There is no single consumer-facing FDA page titled "all FDA-approved peptides." However, many FDA-approved medications are peptide-based, peptide-like, or peptide-derived therapies.
Below are categories of FDA-approved peptide or peptide-based medications commonly used in clinical medicine.
1. GLP-1 and Incretin-Based Medications
These are among the most widely discussed peptide-based therapies today.
| Active ingredient | Common FDA-approved use category |
|---|---|
| Semaglutide | Type 2 diabetes and chronic weight management, depending on product |
| Tirzepatide | Type 2 diabetes and chronic weight management, depending on product |
| Liraglutide | Type 2 diabetes and chronic weight management, depending on product |
| Exenatide | Type 2 diabetes |
| Dulaglutide | Type 2 diabetes |
| Lixisenatide | Type 2 diabetes |
These medications are prescription therapies. They may affect appetite, satiety, glucose regulation, and metabolic signaling, but they are not appropriate for everyone. They should be prescribed and monitored by a licensed clinician.
2. Insulin and Insulin Analogs
Insulin is one of the most established peptide/protein-based therapies in medicine.
| Active ingredient | Common FDA-approved use category |
|---|---|
| Human insulin | Diabetes |
| Insulin lispro | Diabetes |
| Insulin aspart | Diabetes |
| Insulin glulisine | Diabetes |
| Insulin glargine | Diabetes |
| Insulin degludec | Diabetes |
| Insulin detemir | Diabetes |
Insulin therapy can be lifesaving, but dosing and monitoring are highly individualized.
3. Glucagon and Glucagon Analogs
Glucagon is a peptide hormone used medically for severe hypoglycemia and certain other clinical indications.
| Active ingredient | Common FDA-approved use category |
|---|---|
| Glucagon | Severe hypoglycemia rescue and other uses depending on product |
| Dasiglucagon | Severe hypoglycemia rescue |
4. Bone and Parathyroid-Related Peptide Therapies
Some FDA-approved peptide medications affect bone metabolism.
| Active ingredient | Common FDA-approved use category |
|---|---|
| Teriparatide | Osteoporosis in certain patients |
| Abaloparatide | Osteoporosis in certain patients |
| Calcitonin-salmon | Certain bone and calcium-related indications |
These are not general wellness peptides. They are prescription therapies for specific medical needs.
5. Hormone-Regulating Peptide Medications
Some peptide-based medications regulate reproductive hormones, sex-hormone signaling, or endocrine pathways.
| Active ingredient | Common FDA-approved use category |
|---|---|
| Leuprolide | Hormone-sensitive conditions |
| Goserelin | Hormone-sensitive conditions |
| Triptorelin | Hormone-sensitive conditions |
| Histrelin | Hormone-sensitive conditions |
| Ganirelix | Fertility-related use |
| Cetrorelix | Fertility-related use |
| Degarelix | Hormone-sensitive prostate cancer-related use |
These therapies act on the GnRH pathway and are used in specific clinical contexts.
6. Somatostatin Analogs
Somatostatin analogs are peptide medications used for certain endocrine, gastrointestinal, and hormone-secreting tumor-related conditions.
| Active ingredient | Common FDA-approved use category |
|---|---|
| Octreotide | Acromegaly, neuroendocrine tumors, and other uses depending on product |
| Lanreotide | Acromegaly and neuroendocrine tumors |
| Pasireotide | Certain endocrine disorders |
7. Other FDA-Approved Peptide-Based Medications
Other FDA-approved peptide or peptide-based therapies are used across gastroenterology, cardiology, infectious disease, endocrinology, pain medicine, and rare disease care.
| Active ingredient | Common FDA-approved use category |
|---|---|
| Teduglutide | Short bowel syndrome |
| Linaclotide | IBS-C and chronic idiopathic constipation |
| Plecanatide | IBS-C and chronic idiopathic constipation |
| Icatibant | Hereditary angioedema attacks |
| Ziconotide | Severe chronic pain in select patients |
| Pramlintide | Diabetes adjunct therapy |
| Tesamorelin | HIV-associated lipodystrophy |
| Oxytocin | Obstetric use |
| Desmopressin | Certain bleeding or fluid-balance conditions |
| Vasopressin | Vasodilatory shock and other uses depending on product |
| Terlipressin | Hepatorenal syndrome in adults with rapid reduction in kidney function |
| Cosyntropin | ACTH stimulation testing |
| Bivalirudin | Anticoagulation |
| Eptifibatide | Antiplatelet therapy |
| Enfuvirtide | HIV treatment |
The key point is this: FDA-approved peptide-based medications are already part of evidence-based medicine. What is new is how aggressively the word "peptide" is being used in consumer wellness marketing.
Which Popular Wellness Peptides Are Not FDA-Approved Drug Products?
Many peptides trending online are not FDA-approved drug products for the uses commonly promoted on social media.
| Peptide | Common online discussion | FDA-approved drug product for these uses? |
|---|---|---|
| BPC-157 | Injury repair, gut healing, inflammation | No |
| TB-500 / thymosin beta-4 fragments | Recovery, tissue repair | No |
| CJC-1295 | Growth hormone support, body composition | No |
| Ipamorelin | Growth hormone support, body composition | No |
| GHK-Cu injections | Skin, hair, recovery | No |
| MOTS-c | Metabolism, longevity | No |
| KPV | Inflammation, gut health | No |
| Epitalon | Longevity, sleep, aging | No |
| DSIP | Sleep | No |
| Semax | Mood, focus, cognition | No |
| Selank | Mood, anxiety, cognition | No |
| Melanotan II | Tanning, libido | No |
Some of these substances appear in FDA compounding materials or advisory committee discussions. That does not make them FDA-approved medications.
A peptide can be discussed by FDA, reviewed by an advisory committee, nominated for compounding consideration, or removed from a "do not compound" category and still not be an FDA-approved drug product.
What Has the FDA Recently Said About Peptides and Compounding?
The FDA has been actively reworking how it treats certain peptides in compounding, and the situation has changed significantly over the past two years. Because this area is moving quickly, the details below reflect the status as of mid-2026 and may continue to evolve.
In September 2023, the FDA placed roughly 19 peptide bulk drug substances into "Category 2" of its interim 503A bulks list. Category 2 identifies substances the agency has flagged as posing significant safety risks, which in practice means "do not compound." That action covered peptides such as BPC-157, TB-500 (thymosin beta-4 fragment), CJC-1295, ipamorelin, AOD-9604, thymosin alpha-1, GHK-Cu, Semax, Selank, KPV, MOTS-c, epitalon, DSIP, and melanotan II, among others. The FDA cited concerns including immunogenicity risk, manufacturing and impurity complexities, and limited human safety data.
Since then, the picture has continued to evolve:
- In late 2024, the FDA's Pharmacy Compounding Advisory Committee (PCAC) reviewed several of these peptides and voted against adding CJC-1295, ipamorelin, AOD-9604, and thymosin alpha-1 to the 503A bulks list.
- In April 2026, the FDA removed a group of peptides from Category 2, including BPC-157, TB-500, KPV, MOTS-c, DSIP, Semax, epitalon, GHK-Cu, and melanotan II, and scheduled them for formal advisory committee review.
- The PCAC is scheduled to discuss BPC-157, KPV, TB-500, and MOTS-c on July 23, 2026, and DSIP (emideltide), Semax, and epitalon on July 24, 2026. A second PCAC meeting expected before the end of February 2027 is slated to cover additional substances, including GHK-Cu and melanotan II.
This is important, but it is easy to misread.
Being removed from Category 2, being nominated, or being scheduled for an advisory committee discussion is not the same as FDA approval. It is not even the same as being authorized for compounding. Before any of these substances can be legally compounded under Section 503A, the FDA must complete a formal notice-and-comment rulemaking process to add it to the bulks list, and the PCAC's vote is only advisory and non-binding. Even then, a compounded peptide is still not an FDA-approved finished drug product.
In other words: a peptide can be discussed by the FDA, reviewed by an advisory committee, and removed from a "do not compound" list, and still not be FDA approved.
One nuance worth noting is that route of administration can matter. GHK-Cu, for example, has generally been treated more permissively for topical or cosmetic use than for injectable use, which has remained under closer scrutiny.
For patients, the practical takeaway has not changed: do not rely on TikTok, Reddit, influencer protocols, or "research-use" websites to decide what to inject or take. Work with licensed clinicians who understand the difference between FDA-approved therapies, compounded medications, contraindications, dosing, monitoring, and quality sourcing.
Are Peptides Safe?
Some peptide-based medications have strong clinical evidence and FDA approval for specific uses. Others do not.
The better question is not "Are peptides safe?" The better questions are:
Which peptide? For what condition? At what dose? By what route? From what source? For which patient? With what monitoring?
A peptide medication that is appropriate for one person may be inappropriate for another. For example, GLP-1 and incretin-based medications may be helpful for some patients with metabolic indications, but they may not be appropriate for people with certain medical histories, medication interactions, gastrointestinal issues, pregnancy-related considerations, or other contraindications.
This is why medical supervision matters.
At Amsara, peptide therapy begins with the person, not the trend. Our providers evaluate your symptoms, medical history, goals, labs, medications, and risk factors before recommending treatment.
Why Peptide Therapy Is Especially Relevant for Women in Perimenopause and Menopause
During perimenopause and menopause, hormonal changes can affect nearly every system in the body. Many women notice changes in:
- Weight and body composition
- Insulin sensitivity
- Muscle tone and recovery
- Sleep quality
- Energy
- Libido
- Mood
- Brain fog
- Skin and hair
- Cardiometabolic risk
Amsara Health was created for women navigating perimenopause, menopause, and beyond. Our care model is designed for women who want personalized, evidence-based support for hormone health, metabolic health, longevity, thyroid optimization, sexual wellness, and midlife vitality.
Peptides may be one part of a broader care plan, but they are not a replacement for comprehensive evaluation. In many cases, the most effective plan may include hormone evaluation, metabolic labs, thyroid assessment, nutrition, resistance training, sleep support, stress physiology, sexual wellness care, and targeted prescription therapy when appropriate.
Peptide therapy should never be treated as a shortcut around the basics. It should be used thoughtfully, clinically, and safely.
How Amsara Health Approaches FDA-Approved Peptide Therapy
At Amsara, our approach is grounded in medical care, not hype.
Our licensed health providers may prescribe FDA-approved peptide-based medications when clinically appropriate. These therapies may relate to metabolic health, weight management, endocrine health, or other approved medical uses, depending on the individual patient.
Our care model emphasizes:
Licensed providers. Your care is guided by trained medical professionals, not influencer protocols.
Personalized assessment. We evaluate symptoms, medical history, medications, risk factors, and labs before recommending treatment.
FDA-approved options when appropriate. When peptide-based therapy is indicated, we prioritize medications with established regulatory pathways and clinical use.
Ongoing monitoring. Peptide medications may require dose adjustments, side-effect monitoring, lab review, and long-term follow-up.
Whole-person women's health. Peptides are not viewed in isolation. We consider hormones, metabolism, thyroid health, sexual wellness, sleep, stress, and longevity goals.
Red Flags: When Peptide Therapy May Not Be Safe
Be cautious if you see any of the following:
- A product labeled "for research use only" being marketed for human use
- Peptides sold online without a prescription
- Claims that a peptide "heals everything"
- No medical history review
- No lab evaluation
- No discussion of side effects or contraindications
- No licensed prescriber
- No pharmacy transparency
- Influencer dosing instructions
- Before-and-after claims that sound too good to be true
Unregulated or gray-market peptides may raise concerns about sterility, purity, dosing accuracy, contamination, mislabeling, and lack of clinical evidence.
FDA Approved Does Not Mean "Right for Everyone"
Even FDA-approved medications are not automatically right for every patient. FDA approval means a specific medication has been reviewed for safety and effectiveness for specific uses. Individual prescribing decisions still require clinical judgment.
A licensed provider should help determine:
- Whether the medication is appropriate for your goals and diagnosis
- Whether you have contraindications
- Whether you need baseline labs
- What dose and schedule are appropriate
- What side effects to watch for
- Whether the therapy should be combined with nutrition, resistance training, hormone care, or other treatments
- When to pause, adjust, or stop treatment
This is especially important for women in midlife, when symptoms often overlap. Fatigue, weight gain, poor sleep, low libido, mood changes, and brain fog can be related to hormones, thyroid function, insulin resistance, stress, nutrient deficiencies, medications, or other medical conditions.
The right answer is rarely "just take a peptide."
The better answer is: let's understand what your body is asking for.
Frequently Asked Questions About FDA-Approved Peptides
Are all peptides FDA approved?
No. Some peptide-based medications are FDA approved, including insulin products, GLP-1 and incretin-based medications, glucagon products, oxytocin, certain hormone-regulating medications, somatostatin analogs, and other prescription therapies. Many peptides marketed online for anti-aging, injury repair, sleep, tanning, recovery, or longevity are not FDA-approved drug products.
Is semaglutide a peptide?
Yes. Semaglutide is a GLP-1 receptor agonist and peptide-based medication used in FDA-approved prescription products for specific metabolic indications.
Is tirzepatide a peptide?
Tirzepatide is a peptide-based medication that acts on incretin pathways, including GIP and GLP-1 receptors. FDA-approved tirzepatide products are prescription medications used for specific metabolic indications.
Is BPC-157 FDA approved?
No. BPC-157 is not an FDA-approved drug product for injury repair, gut healing, inflammation, or general wellness use. The FDA removed BPC-157 from its "do not compound" Category 2 list in 2026 and scheduled it for advisory committee review, but removal from that category is not the same as FDA approval, and it is not the same as authorization to compound.
Is TB-500 FDA approved?
No. TB-500 is not an FDA-approved drug product for recovery, wound healing, or performance-related use.
Are compounded peptides FDA approved?
Compounded medications are generally not FDA-approved finished drug products. Compounding may be appropriate in certain clinical circumstances when performed by qualified pharmacies under applicable law, but it is not the same as FDA approval. The FDA's ongoing compounding review of certain peptides does not make those peptides FDA approved.
Can peptides help with menopause symptoms?
Some peptide-based medications may be relevant to metabolic health, body composition, or other concerns that can become more noticeable during perimenopause and menopause. However, menopause-related symptoms should be evaluated comprehensively. Hormones, thyroid function, sleep, nutrition, stress, sexual health, and cardiometabolic risk may all play a role.
Does Amsara prescribe peptides?
Amsara's licensed health providers may prescribe FDA-approved peptide-based medications when clinically appropriate. Care is personalized and based on medical history, symptoms, labs, goals, contraindications, and ongoing monitoring.
The Bottom Line: Peptides Are Not Just a Trend. But They Do Require Medical Judgment.
Peptides are having a cultural moment, but they are not new to medicine. Some are among the most important therapies in modern healthcare. Others are experimental, overhyped, or being marketed faster than the evidence can support.
The difference matters.
At Amsara Health, we help women cut through the noise with licensed, personalized, medically grounded care. When FDA-approved peptide-based therapy is appropriate, our providers can prescribe it as part of a broader plan designed for your hormones, metabolism, longevity, and quality of life.
Because your body is changing. Your care should evolve with it.
Schedule an appointment with an Amsara Health certified provider →
This article is for educational purposes and is not a substitute for individualized medical advice. Please consult a qualified healthcare provider for guidance specific to your health.